1. Azathioprine: friend or foe?. (1st May 2019) Authors: Leigh, I.M.; Proby, C.M.; Inman, G.J.; Harwood, C.A. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 961 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Azathioprine: friend or foe?. (26th April 2019) Authors: Leigh, I.M.; Proby, C.M.; Inman, G.J.; Harwood, C.A. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 961 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Fatal attractions? Correlations of CXCL12–CXCR4–CXCR7 expression with disease progression in melanoma and Kaposi sarcoma. (1st December 2016) Authors: Spender, L.C.; Inman, G.J. Journal: British journal of dermatology Issue: Volume 175:Number 6(2016) Page Start: 1140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Fatal attractions? Correlations of CXCL12–CXCR4–CXCR7 expression with disease progression in melanoma and Kaposi sarcoma. (December 2016) Authors: Spender, L.C.; Inman, G.J. Journal: British journal of dermatology Issue: Volume 175:Number 6(2016) Page Start: 1140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Heterogeneous addiction to transforming growth factor‐beta signalling in recessive dystrophic epidermolysis bullosa‐associated cutaneous squamous cell carcinoma. (1st April 2021) Authors: Dayal, J.H.S.; Mason, S.M.; Salas‐Alanis, J.C.; McGrath, J.A.; Taylor, R.G.; Mellerio, J.E.; Blyth, K.; South, A.P.; Inman, G.J. Journal: British journal of dermatology Issue: Volume 184:Number 4(2021) Page Start: 697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Heterogeneous addiction to transforming growth factor‐beta signalling in recessive dystrophic epidermolysis bullosa‐associated cutaneous squamous cell carcinoma. (9th October 2020) Authors: Dayal, J.H.S.; Mason, S.M.; Salas‐Alanis, J.C.; McGrath, J.A.; Taylor, R.G.; Mellerio, J.E.; Blyth, K.; South, A.P.; Inman, G.J. Journal: British journal of dermatology Issue: Volume 184:Number 4(2021) Page Start: 697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Melanoma secretion of transforming growth factor‐β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration. (1st April 2022) Authors: Cosgarea, I.; McConnell, A.T.; Ewen, T.; Tang, D.; Hill, D.S.; Anagnostou, M.; Elias, M.; Ellis, R.A.; Murray, A.; Spender, L.C.; Giglio, P.; Gagliardi, M.; Greenwood, A.; Piacentini, M.; Inman, G.J.; Fimia, G.M.; Corazzari, M.; Armstrong, J.L.; Lovat, P.E. Journal: British journal of dermatology Issue: Volume 186:Number 4(2022) Page Start: 694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Melanoma secretion of transforming growth factor‐β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration. (27th December 2021) Authors: Cosgarea, I.; McConnell, A.T.; Ewen, T.; Tang, D.; Hill, D.S.; Anagnostou, M.; Elias, M.; Ellis, R.A.; Murray, A.; Spender, L.C.; Giglio, P.; Gagliardi, M.; Greenwood, A.; Piacentini, M.; Inman, G.J.; Fimia, G.M.; Corazzari, M.; Armstrong, J.L.; Lovat, P.E. Journal: British journal of dermatology Issue: Volume 186:Number 4(2022) Page Start: 694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗